📰 Ichnos Sciences News
Page 3 - Ichnos Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ichnos Sciences. Real-time updates on events, politics, business and more.
November 3, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...
September 28, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...
September 22, 2022
Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases The Phase I study will evaluate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of ALM27134* ALM27134 has the potential to treat underserved patien...
August 11, 2022
Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd
June 7, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, today...
June 7, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, announced that...
June 7, 2022
Updated Presentation Date and TimeNEW YORK, June 7, 2022 /PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company devel...
May 26, 2022
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
May 25, 2022
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
April 19, 2022
/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the...